3Kullberg A, Larsen J, Sharp L.Why is there another per- son's name on my infusion bag? Patient safety in chem- otherapy care A review of the literature[J]. Eur J Oncol Nurs, 2013,17 (2) : 228-235.
4Jacobson J O, Polovich M,Gilmore T R, et al.Revisions to the 2009 American Society of Clinical Oncology/On- cology Nursing Society chemotherapy administrationsafety standards: Expanding the scope to include inpa- tient settings[J]. Oncol Nurs Forum, 2012,39 ( 1 ) : 31-38.
5Teefey P, Bou Zgheib N, Apte S M, et al.Factors associ- ated with improved toxicity and tolerability of intraper- itoneal chemotherapy in advanced-stage epithelial ovari- an eaneers[J].Am J Obstet Gynecol,2013,208(6) : 501- 507.
6Viale P H,Grande C, Moore S. Efficacy and cost: avoi- ding undertreatment of chemotherapy-induced nausea and vomiting[J]. Clin J Oncol Nurs, 2012,16 ( 4 ) :133- 141.
7Phillips K M,Faul L A,Small B J,et al.Comparing the retrospective reports of fatigue using the fatigue symp- tom index with daily diary ratings in women receiving chemotherapy for gynecologic cancer[J].J Pain Symp- tom Manage, 2013,46 (2) : 282-288.
8Sun V, Otis-Green S, Morgan R, et al.Toxicities, compli- cations, and clinical encounters during intraperitoneal chemotherapy in:17 women with ovarian cancer[J].Eur J Oncol Nurs,2013,17(3) : 375-380.
9Whitford H S,Olver I N.When expectations predict ex- perience : The influence of psychological factors on chem- otherapy toxieities[J]. Pain Symptom Manage, 2012,43 (6) : 1036-1050.
10Woolery M, Bisanz A,Lyons H F, et al.Putting evidence into practice: Evidence-based interventions for the pre- vention and management of constipation in patients with cancer[J].Clin J Oncol Nurs,2008,12(2) :317-337.
